Last reviewed · How we verify
Itraconazole Oral Product
At a glance
| Generic name | Itraconazole Oral Product |
|---|---|
| Sponsor | Gynaecologisch Oncologisch Centrum Zuid |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis (PHASE1)
- A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participants (PHASE1)
- Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole (PHASE1)
- A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine) (PHASE1)
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors (PHASE1, PHASE2)
- Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers (PHASE1)
- Drug Interaction and Food Effect Study of CS0159 (PHASE1)
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Itraconazole Oral Product CI brief — competitive landscape report
- Itraconazole Oral Product updates RSS · CI watch RSS
- Gynaecologisch Oncologisch Centrum Zuid portfolio CI